Assetmark Inc. Buys 37,939 Shares of The Cooper Companies, Inc. $COO

Assetmark Inc. grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 20.6% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 222,349 shares of the medical device company’s stock after buying an additional 37,939 shares during the period. Assetmark Inc.’s holdings in Cooper Companies were worth $15,898,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Wellington Management Group LLP grew its position in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Generation Investment Management LLP acquired a new position in Cooper Companies in the 4th quarter valued at approximately $233,539,000. Diamond Hill Capital Management Inc. lifted its position in shares of Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after acquiring an additional 2,720,594 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares during the period. Finally, Franklin Resources Inc. grew its holdings in shares of Cooper Companies by 108.2% during the 4th quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after purchasing an additional 2,089,763 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $71.71 on Monday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The stock has a 50 day simple moving average of $66.24 and a 200-day simple moving average of $72.52. The stock has a market cap of $13.99 billion, a PE ratio of 60.77, a PEG ratio of 1.87 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on COO. Stifel Nicolaus lowered their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Citigroup reissued a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a report on Wednesday, July 8th. Finally, Wells Fargo & Company restated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $81.85.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.